Library
Every article, one place
250 evidence-based guides and explainers, each medical-reviewer signed. Search the full library or filter by goal.
250 articles
- Growth Hormone✦ reviewed
Tesamorelin & GH peptides: numb hands, swelling & carpal tunnel explained (2026)
Numb hands, swelling and water weight on tesamorelin or CJC-1295/ipamorelin? It's GH-driven fluid retention compressing the median nerve. Why it happens and what to do.
- Growth Hormone✦ reviewed
CJC-1295 + Ipamorelin stack: the GHRH+GHRP protocol explained (2026)
Why dual-pathway GH activation produces 2-3x greater effect. Protocol, with-DAC vs without-DAC, costs, WADA status, and how it compares to sermorelin + rhGH.
- Growth Hormone✦ reviewed
CJC-1295, ipamorelin and tesamorelin: adverse effects of the GH stack (2026)
Tesamorelin and CJC-1295 are both GHRH analogues acting on the same receptor, so the three-compound stack concentrates one side-effect profile rather than adding three. Fluid retention and numbness are what to watch, and why.
- Growth Hormone✦ reviewed
GH peptide cycling, washout & switching: CJC-1295, ipamorelin, HGH (2026)
GH secretagogues desensitize the GH-release pathway — the real reason they're cycled. Switching between GHRH/GHRP peptides needs no formal washout; moving to or from HGH does need care. Pulsatile dosing, breaks, and why higher doses backfire.
- Recovery✦ reviewed
TB-500 vs BPC-157: when to use which, when to stack (2026 evidence guide)
Honest comparison: when BPC-157 alone is the right choice, when to add TB-500, when post-surgical recovery justifies the stack from week 1, WADA status of both.
- Growth Hormone
Age-related GH decline: when to intervene + which peptide (2026)
When GH-axis intervention is reasonable, baseline labs to order, IGF-1 target (mid-normal for age), and the decision tree across sermorelin, CJC+Ipa, tesamorelin.
- ✦ reviewed
Common beginner peptide mistakes (and how to avoid them) (2026)
The six predictable mistakes peptide beginners make — cheapest-source chasing, dosing errors, over-expectation, skipping safety checks, dose-chasing, skipping the basics — and how to avoid each.
- Recovery✦ reviewed
Recovery peptides: course vs cycle (BPC-157, TB-500) (2026)
BPC-157 and TB-500 are run as finite healing courses, not cycled. Why the schedule follows the injury timeline, and why indefinite 'maintenance' use isn't supported.
- Cognitive✦ reviewed
Nootropic peptide cycling: Semax, Selank, and the tolerance question (2026)
Semax's focus effect blunts with daily use, so cycling or intermittent use is recommended; Selank is reported less tolerance-prone. Conventions, not proven schedules.
- ✦ reviewed
Peptide cycling and breaks: do you actually need them? (2026)
Whether to cycle a peptide depends on its mechanism. Which peptides build tolerance and need breaks, which run as finite courses, and which are continuous.
- ✦ reviewed
Should I get a pharmacogenomic panel before starting peptides? A 2026 decision flowchart
Five scenarios where PGx testing pays for itself before peptide therapy, plus when standard bloodwork is enough. What test to order, what 'peptide PGx panels' really are.
- Longevity✦ reviewed
SLU-PP-332: does the 'exercise in a pill' actually work? (2026)
SLU-PP-332 is an exercise-mimetic ERR agonist that drives fat loss and endurance in mice. The honest evidence: zero human data, not FDA-approved, not a peptide.
- Weight Loss✦ reviewed
Survodutide (BI 456906): the glucagon/GLP-1 dual agonist explained (2026)
Survodutide is an investigational glucagon/GLP-1 dual agonist — up to ~19% weight loss and ~62% MASH resolution in Phase 2. How it works and how it compares.
- Immune & Gut✦ reviewed
Peptides for immune and gut health (2026): BPC-157, KPV, thymosin alpha-1, LL-37
Which immune and gut peptides work: BPC-157 (barrier repair), KPV (anti-inflammatory), thymosin alpha-1 (immune modulation), LL-37. Evidence-tier breakdown.
- Cognitive✦ reviewed
Peptides for post-concussion and TBI cognitive recovery: what the evidence supports (2026)
Cerebrolysin has the most TBI-recovery evidence; Semax and neurotrophic peptides have rationale. Peptides as adjuncts to standard concussion care, timing, risks.
- ✦ reviewed
Pharmacogenomics and peptide therapy (2026): what your genes mean for dosing, side effects, and response
Which peptides are affected by genetics, when CYP variants matter for oral vs injectable GLP-1, the Wilson's + GHK-Cu interaction, when peptide PGx panels are marketing.
- Cognitive✦ reviewed
Semax vs Selank: stimulating vs calming nootropic peptides compared (2026)
Semax (focus, stimulating) vs Selank (calm, anxiolytic) compared. Which for focus, which for anxiety, how to stack both, dosing, tolerance, N-acetyl versions.
- Longevity✦ reviewed
Senolytics vs senomorphics: two strategies for cellular aging, compared (2026)
Two approaches to cellular aging compared: senolytics clear senescent cells, senomorphics quiet their signaling. Evidence tier, FOXO4-DRI, rapamycin, fisetin.
- Cognitive✦ reviewed
Intranasal neuropeptide delivery: how nose-to-brain bypass actually works
Olfactory and trigeminal pathways explained. Why nasal route bypasses BBB, bioavailability data, formulation factors, technique that actually matters.
- Longevity✦ reviewed
Why most longevity peptide stacks don't survive evidence scrutiny (2026)
Most marketed longevity peptide stacks are mechanism + marketing. The evidence-supported core is 2–4 peptides. Cut Epitalon, MOTS-c, Klotho, FOXO4-DRI.
- Weight Loss✦ reviewed
MariTide (maridebart cafraglutide): the monthly obesity shot explained (2026)
MariTide is Amgen's monthly GLP-1/GIP-antagonist obesity drug — up to ~20% weight loss in Phase 2. How the unusual mechanism, dosing, and tolerability stack up.
- Skin & Anti-Aging✦ reviewed
Melanotan-II side effects & melanoma risk: what to know (2026)
Melanotan-II side effects and the serious concern: it darkens/changes moles and is linked to melanoma in case reports. Plus nausea, priapism, and who must avoid it.
- Cognitive✦ reviewed
Peptides for cognitive performance (2026): Semax, Cerebrolysin, Dihexa and what works
Which cognitive peptides work: Semax (focus), Selank (calm), Cerebrolysin (recovery), Dihexa. Evidence-tier breakdown, matching peptide to goal.
- Weight Loss✦ reviewed
CYP3A4 and oral GLP-1 (Rybelsus): when your metabolism status actually matters
How CYP3A4 status affects oral semaglutide (Rybelsus) but not injectable Ozempic / Wegovy. Drug interactions, when to test, when to switch to injectable.
- Skin & Anti-Aging
GHK-Cu is more than skincare: the genomic, anti-cancer, and systemic biology (2026 evidence review)
Fact-checking the viral GHK-Cu claims: 51% collagen, 31% genome 'reset', vs Matrixyl 3000, cancer apoptosis. What the studies actually show, by evidence tier.
- Skin & Anti-Aging✦ reviewed
GLOW vs KLOW: what does adding KPV change? (2026)
KLOW is GLOW plus KPV. What the extra anti-inflammatory peptide adds, whether it's worth it, and the honest evidence — no human data on either combination.
- Immune & Gut✦ reviewed
Gut barrier repair compared: BPC-157 vs KPV vs larazotide (2026)
Compare the three main gut barrier repair agents — BPC-157 (repair), KPV (anti-inflammatory), larazotide (tight-junction). Evidence tiers and how to match.
- Weight Loss✦ reviewed
Bimagrumab: the drug that builds muscle while losing fat (2026)
Bimagrumab is an activin-receptor antibody that lost ~20.5% fat while gaining muscle in Phase 2 — now studied with semaglutide to preserve muscle on GLP-1s.
- Recovery✦ reviewed
Is BPC-157 legal in 2026? The FDA Interim Category 2 status explained
BPC-157 and TB-500 currently FDA Interim Category 2. July 23 2026 PCAC meeting will formally evaluate. What status means, three plausible outcomes, what patients should do.
- Skin & Anti-Aging✦ reviewed
Veradermics' hair-loss pill cleared Phase 3. It's minoxidil (2026)
536 men, 28.6 and 36.4 hairs/cm² versus 6.6 for placebo at six months. But VDPHL01 is extended-release oral minoxidil, not a new drug — and what is actually new is that someone ran the registration trials.
- Weight Loss✦ reviewed
Does Ozempic cause hair loss? GLP-1s, shedding & how to prevent it (2026)
Yes, some shed hair on Ozempic/Mounjaro — but it's telogen effluvium from rapid weight loss, not the drug, and it's temporary. Why it happens and how to prevent it.
- Skin & Anti-Aging✦ reviewed
Topical rapamycin for hair loss: good mechanism, no trial
mTORC1 does suppress hair follicle growth — but no trial tests topical rapamycin alone for hair loss, and products bundle it with finasteride and minoxidil.
- Skin & Anti-Aging✦ reviewed
Minoxidil-free hair serums: what the evidence actually supports
Caffeine matched minoxidil in a 210-man trial. Adenosine beat placebo double-blind. Methyl vanillate has one uncontrolled pilot. What's real and what isn't.
- Skin & Anti-Aging✦ reviewed
GHK-Cu and microneedling for hair: the protocol (2026)
How to combine microneedling, minoxidil, and GHK-Cu for hair safely: depth and frequency, why not to apply peptides into fresh channels, and realistic timelines.
- Skin & Anti-Aging✦ reviewed
Peptides for hair loss: what the evidence actually shows (2026)
Peptides are an adjunct for hair loss, not the fix. Minoxidil and finasteride are the proven base; microneedling boosts minoxidil; GHK-Cu has limited human data.
- Skin & Anti-Aging✦ reviewed
Oral minoxidil for hair loss: what the evidence actually supports (2026)
Prescribed off-label at 0.25-5 mg daily, with efficacy comparable to topical minoxidil and better adherence. Nearly all the evidence is retrospective — which is why hypertrichosis is reported at 15% in chart reviews and 71.6% when women are asked directly.
- Weight Loss✦ reviewed
Peptides in Benelux: the region that regulated the prescriber, not the border
Belgium required an endocrinologist for the first GLP-1 prescription by Royal Decree. The Netherlands reimburses Saxenda but not Wegovy. Nobody criminalises possession.
- Weight Loss✦ reviewed
Peptides in Iberia: Portugal has Europe's harshest possession rule, and almost nobody says so
Portugal criminalises holding a listed substance with no quantity threshold at all — up to five years, for anyone. And INFARMED does not authorise personal import.
- Weight Loss✦ reviewed
Peptides in Central & Eastern Europe: where the reputations are backwards
Romania: 2–7 years for import, harsher than trafficking. Czechia: criminal possession above one vial. Greece's 10-year penalties mostly don't reach gym users.
- Recovery✦ reviewed
BPC-157 protocol guide (2026): dosing, injection sites, and cycle structure for tendinopathy
Operational BPC-157 protocol: dose by indication, injection sites for tendons + joints, syringe / reconstitution detail, cycle length, when to add eccentric loading PT.
- Weight Loss✦ reviewed
Compounded GLP-1s: 503A, 503B and why the shortage route closed
Tirzepatide's shortage ended 19 Dec 2024, semaglutide's 21 Feb 2025. Compounders sued twice and lost. Now the FDA wants all three off the 503B bulks list.
- Growth Hormone✦ reviewed
GH peptides for muscle: the honest evidence (2026)
Do MK-677, CJC-1295, and ipamorelin build muscle? They raise IGF-1, but gains are modest, partly water, and inconsistent on strength. The honest, evidence-based take.
- Weight Loss✦ reviewed
Can you legally buy retatrutide? No — and the import alert isn't what people think
Unapproved everywhere, no application filed, Q1 2027 target. And the August 2026 import alert entry is a detention exclusion — not an approval.
- ✦ reviewed
Flying with peptides & injectables: TSA, cold chain, documentation (2026)
How to fly with peptide injectables: carry-on only, declaring liquids and needles at security, prescriptions and documentation, and keeping the cold chain in the air.
- Weight Loss✦ reviewed
GLP-1 side effects and how to manage them (2026)
Most GLP-1 side effects are GI and dose-related — slow titration and diet manage them. The heart-rate bump explained, plus the red flags that mean stop.
- Growth Hormone✦ reviewed
Peptides in Germany, Austria and Switzerland: the 1.5 mg threshold nobody mentions
Germany sets 1.5 mg for GHRPs against 150 mg for secretagogues — a hundredfold gap. Possession above threshold is criminal for anyone, not just athletes.
- ✦ reviewed
Are peptides legal? US law, importing, and by-compound status (2026)
Are peptides legal in the US? A few GLP-1s are FDA-approved; most research peptides like BPC-157 and CJC-1295 are unapproved. Importing rules and by-compound status.
- Weight Loss✦ reviewed
Amycretin (zenagamtide): Novo's oral & injectable GLP-1/amylin drug (2026)
Amycretin has been renamed zenagamtide. Fifteen Phase 3 trials are registered across obesity and type 2 diabetes, enrolling ~23,000 people — including a 950-person trial of the oral tablet. None has reported.
- Weight Loss✦ reviewed
Are peptides safe for older adults? What the evidence does and doesn't say (2026)
For most peptides the honest answer at 70, 80 or 90 is that nobody has studied it. For GLP-1 drugs there is evidence — and it shows muscle, grip strength and gait speed declining, with fragility fracture risk modestly up in over 46,000 adults aged 65+.
- Cognitive✦ reviewed
Cerebrolysin: neurotrophic protocol for stroke, TBI, dementia (2026)
How cerebrolysin is actually administered — IV, IM and intranasal — typical course structure, and the regulatory position in the US, EU and the countries where it is approved.
- Cognitive✦ reviewed
Cerebrolysin: what the evidence actually shows (2026)
Cerebrolysin has genuine randomised evidence across stroke, TBI and dementia — and consistently modest effect sizes. A trial-by-trial read of what holds up.
- Weight Loss✦ reviewed
GLP-1 weight-loss plateau: why it happens and what to do (2026)
Plateaus on a GLP-1 are normal, not failure. Why loss is non-linear, why escalating into a stall backfires, and the fundamentals to check before changing the dose.
- Weight Loss✦ reviewed
One in eight teenagers on a GLP-1 got a vitamin D deficiency diagnosis. Fewer than one in four saw a dietitian
2,031 adolescents, one year on a GLP-1: 12.4% got a vitamin D deficiency diagnosis. Why that number is weaker than it looks, and why the counselling figure matters more.
- Cognitive✦ reviewed
The love hormone that wasn't: what sixty years of oxytocin research actually proved
The trust study failed replication twice. A 2026 meta-analysis of 733 people found nothing. Voles without the receptor still pair bond. What oxytocin research actually proved.
- Weight Loss✦ reviewed
Muscle loss on GLP-1s: how to prevent it (2026)
Losing muscle on tirzepatide or semaglutide? It's real but preventable. Protein (1.6 g/kg), resistance training, sensible pace. Why peptides are minor by comparison.
- Sexual Health✦ reviewed
Sexual health peptides for women (2026): PT-141, kisspeptin, oxytocin and HSDD
PT-141 (Vyleesi) is FDA-approved for female HSDD. Kisspeptin and oxytocin evidence, when to check hormones first, peri/postmenopausal considerations.
- Sexual Health✦ reviewed
Peptides for sexual health (2026): PT-141, kisspeptin, oxytocin and what actually works
Which sexual-health peptides work: PT-141 (FDA-approved), kisspeptin, oxytocin. How they differ from Viagra-class drugs, arousal vs erectile mechanisms, women's use.
- Sexual Health✦ reviewed
Oxytocin side effects: physical, emotional & placebo (2026)
Intranasal oxytocin's side effects: mild physical ones (nasal irritation, headache), real emotional ones (anxiety, irritability), and why many effects match placebo.
- Sexual Health✦ reviewed
Oxytocin nasal for sexual bonding and performance anxiety: 2026 evidence guide
Why oxytocin works for the bonding layer of sex (not libido or erections). Honest evidence on intranasal use, context dependence, dosing, and who should consider it.
- Longevity✦ reviewed
A new creatine trial reports lean mass and memory gains. Here is what it actually shows
A 12-week trial in 64 adults aged 45-65 found creatine plus exercise added 1.27 kg lean mass while dieting. The design detail, the exploratory cognition data, and the disclosure worth reading.
- Recovery✦ reviewed
Five injuries BPC-157 healed — in rats. And the dihexa papers nobody mentioned were retracted
Five injuries BPC-157 healed were four rat studies and one rabbit study. Dihexa's mechanism papers were retracted in 2025. And a real Phase 2 trial is finally recruiting.
- Weight Loss✦ reviewed
Preserving lean mass while cutting: where peptides fit (2026)
Keep muscle while cutting with three proven levers: moderate deficit, high protein, resistance training. Why peptides are a marginal add-on, not the solution.
- Immune & Gut✦ reviewed
Creatine and dendritic cells: what the UCLA paper found, and what the viral thread added
The viral claim that depleting dendritic cells abolished creatine's anti-tumour effect is not in the UCLA paper. What it really showed, the injected dose, and the null human trial the thread left out.
- Recovery✦ reviewed
Why your BPC-157 might not be working: vendor quality, dose, route, and diagnosis (2026)
Four causes account for almost all BPC-157 non-response at week 6. Diagnostic decision tree for vendor quality, dose, route, and underlying diagnosis. When to stop and get imaging.
- ✦ reviewed
Peptide safety and sourcing: the practical guide (2026)
The real risks are a bad source, wrong dose, and poor technique. How to verify a vendor, read a COA, reconstitute correctly, and spot side effects that mean stop.
What 2,271 peptide Reddit posts reveal about the community (2026)
We analyzed 2,271 peptide Reddit posts: GLP-1s dominate ~59% of mentions, dosing & titration is the #1 topic. Community-signal data, not evidence.
- Cognitive✦ reviewed
Selank for anxiety and cortisol: how the Russian anxiolytic peptide works
Russian intranasal peptide for anxiety + cortisol modulation. No sedation, no tolerance, no withdrawal. How it compares to standard anxiolytics, evidence tier, dosing protocol.
- Weight Loss✦ reviewed
GLP-1s for women: PCOS, fertility, and cycle effects (2026)
GLP-1s improve PCOS weight, insulin resistance, and cycle regularity, can restore ovulation, may affect oral contraception, and need a pre-conception stop.
- Weight Loss✦ reviewed
Tirzepatide deep dive: the evidence, the dosing, the trade-offs (2026)
Tirzepatide is a dual GIP/GLP-1 agonist with ~20%+ average weight loss that beat semaglutide head-to-head. The evidence, side effects, class cautions, and who it's for.
- Cognitive✦ reviewed
Are you supposed to feel Semax & Selank? What nootropic peptides feel like (2026)
Semax and Selank aren't stimulants — most people don't feel a hit. What nootropic peptides feel like, how to tell if they're working, and why you might feel nothing.
- Skin & Anti-Aging✦ reviewed
Peptide injection-site discoloration: is the staining normal? (2026)
GHK-Cu injection sites turning blue-grey or brown? Copper staining and post-inflammatory hyperpigmentation are usually benign. Why it happens, how to fade it, red flags.
- Weight Loss✦ reviewed
Semaglutide deep dive: the evidence, the dosing, the trade-offs (2026)
Semaglutide (Ozempic, Wegovy, Rybelsus) is the most established GLP-1: ~15% weight loss and proven cardiovascular benefit from SELECT. Side effects and who it's for.
- Sexual Health✦ reviewed
TRT and peptides: how they fit together (2026)
How TRT and peptides combine: fertility preservation (hCG, kisspeptin), GH-peptide body-composition stacking, and libido add-ons — plus the HPG-shutdown interaction.
- Sexual Health✦ reviewed
Protecting fertility & the HPG axis on TRT: hCG and kisspeptin (2026)
TRT shuts down the HPG axis and impairs sperm production. How hCG preserves testicular function and fertility, where kisspeptin fits, and why to plan before starting TRT.
- Recovery✦ reviewed
Peptides for muscle growth and body recomposition: the honest guide (2026)
Do peptides build muscle? Mostly no. GH secretagogues give modest, partly-water gains; recovery peptides help indirectly. The real win is preserving lean mass on GLP-1s.
- Recovery✦ reviewed
Peptides for surgery recovery: what's safe, what's hype (2026)
BPC-157, TB-500 & GHK-Cu for post-op healing: the evidence is preclinical, no surgical human trials exist, and peri-operative use carries real risks. Ask your surgeon.
- ✦ reviewed
Labs to run before and during peptides (2026)
What bloodwork to get before and during peptide use: baseline panels, mechanism-matched markers (IGF-1, glucose), how often to test, and why a clinician should interpret results.
- Recovery✦ reviewed
The 'KLOW' healing stack: what's in it and does it work? (2026)
KLOW blends BPC-157, TB-500, GHK-Cu, and KPV as a recovery stack. Component evidence is uneven, the combination is untested in humans, and stacking multiplies the risk.
- ✦ reviewed
Independent peptide lab testing: purity, heavy metals, endotoxin (2026)
In an unregulated market, third-party testing is the only proof of what's in a vial. The tests that matter — purity, heavy metals, endotoxin — and COA red flags.
- Skin & Anti-Aging✦ reviewed
The GLOW protocol (GHK-Cu + BPC-157 + TB-500): does it work? (2026)
GLOW stacks GHK-Cu, BPC-157 and TB-500 for skin and healing. The honest evidence: strong on parts, zero human data on the combination, and gray-market sourcing.
- ✦ reviewed
At-home peptide test kits: can you verify without a lab? (2026)
Can home test kits verify BPC-157 or TB-500 are real and pure? Mostly no — only HPLC/mass-spec (a real lab or COA) confirms identity, purity and contamination.
- Skin & Anti-Aging✦ reviewed
Argireline (acetyl hexapeptide-8): what it is and does it work? (2026)
Argireline is acetyl hexapeptide-8, a topical Botox-like peptide. How it works, honest evidence on wrinkles, why penetration limits it, and how it compares to Botox.
- Weight Loss✦ reviewed
Stopping a GLP-1: rebound, weight regain & feeling worse off than on (2026)
What happens when you stop Ozempic, Wegovy or Mounjaro: appetite returns, ~two-thirds weight regain, cardiometabolic reversal — and why it isn't true withdrawal.
- Immune & Gut✦ reviewed
Thymosin alpha-1 vs thymosin beta-4: two different peptides (2026)
Thymosin alpha-1 (immune modulation, real RCTs) vs thymosin beta-4 / TB-500 (tissue repair, preclinical). Why the similar names mislead, and which does what.
- Weight Loss✦ reviewed
Is tirzepatide (Mounjaro) available in the EU? (2026)
Tirzepatide is EMA-approved across the EU as Mounjaro — one brand for diabetes and weight loss, prescription only, injectable only. Barriers are cost and supply.
- Longevity✦ reviewed
Vilon (Lys-Glu): the dipeptide bioregulator — evidence & honest review (2026)
Vilon is a synthetic Lys-Glu dipeptide from the Khavinson bioregulator family. The real (mostly Russian, preclinical) evidence, dosing, safety, and vs Epitalon.
- ✦ reviewed
Your first peptide cycle: a step-by-step walkthrough (2026)
Run your first peptide cycle safely: define the goal, source and verify, reconstitute and dose accurately, inject cleanly, track, and evaluate. The complete beginner walkthrough.
- Weight Loss✦ reviewed
Is semaglutide available in the EU? Ozempic, Wegovy & Rybelsus (2026)
Semaglutide is EMA-approved across the EU by prescription — Wegovy, Ozempic, and oral Rybelsus. The real barriers are eligibility, cost, and shortages, not legality.
- Weight Loss✦ reviewed
Retatrutide vs semaglutide: how they compare (2026)
Retatrutide vs semaglutide compared: triple agonist vs GLP-1, ~24-28% vs ~15% trial weight loss, side effects, and the key gap — only semaglutide is FDA-approved.
- Weight Loss✦ reviewed
Is retatrutide available in the EU? Pipeline status (2026)
Retatrutide is not available in the EU — still investigational in phase 3, no EMA approval, no legal route. Options: a clinical trial, or an approved GLP-1 for now.
- Weight Loss✦ reviewed
Retatrutide dosing & how to start: what the trials show (2026)
Retatrutide isn't approved, so dosing comes from trials: start 2 mg weekly, escalate every 4 weeks. Why slow ramping limits nausea and heart-rate spikes people report.
- Weight Loss✦ reviewed
Retatrutide deep dive: the triple agonist explained (2026)
Retatrutide is an investigational GIP/GLP-1/glucagon triple agonist with ~24% phase-2 weight loss. Mechanism, evidence, side effects, and the gray-market risk.
- ✦ reviewed
Research-grade vs pharmaceutical-grade vs compounded peptides: what you're really buying (2026)
What 'research grade,' 'compounded,' and 'pharmaceutical grade' really mean — the oversight, quality, and price differences, and why 'research grade' is no quality guarantee.
- ✦ reviewed
Popular peptide stacks ranked by evidence (2026)
The most-discussed peptide stacks ranked by evidence, not hype: BPC-157+TB-500 and CJC-1295+ipamorelin lead; longevity and 'ultimate' stacks are mostly Tier 5.
- Weight Loss✦ reviewed
Petrelintide: the amylin analog with better tolerability? (2026)
Petrelintide (Zealand/Roche) hit ~10.7% weight loss in Phase 2 — with reportedly no vomiting at the top dose. Why its tolerability may matter more than the number.
- Immune & Gut✦ reviewed
Peptides for SIBO and gut dysbiosis: adjuncts, not cures (2026)
Peptides don't clear SIBO or rebalance the microbiome. Where BPC-157 and KPV fit — the gut-healing phase — and why treating the cause matters most.
- Recovery✦ reviewed
Peptides and resistance training: the recovery synergy (2026)
The real peptide-training synergy is recovery, not muscle growth. How recovery and GH peptides fit lifting — and why sleep, protein, and programming matter far more.
- Skin & Anti-Aging✦ reviewed
Peptides for hyperpigmentation & melasma: do they work? (2026)
Peptides are a minor adjunct for pigmentation, not the fix. The evidence: sunscreen, tranexamic acid, niacinamide, retinoids, azelaic acid, plus why melasma is stubborn.
- Longevity✦ reviewed
Peptides for seniors: what's worth it, what's risky (2026)
Peptides for older adults: muscle, recovery, metabolic health. Why age raises the risk (interactions, IGF-1/cancer), what's actually proven, and safer alternatives.
- Immune & Gut✦ reviewed
Peptides and autoimmune conditions: what's plausible, what's risky (2026)
Which peptides have an autoimmune rationale (thymosin alpha-1, KPV) and which are risky (LL-37). Why 'immune boosting' is the wrong frame. Evidence tiers.
- ✦ reviewed
Peptides and fasting: timing, interactions & muscle (2026)
How fasting interacts with peptides: it raises your own GH (relevant to GH-peptide timing) but on GLP-1s hard fasting risks muscle loss. What matters, what's myth.
- ✦ reviewed
Too-good-to-be-true peptide pricing: the red flags (2026)
A suspiciously cheap peptide usually means underdosed, untested, or counterfeit. The documented counterfeit problem, the red flags that stack, and the scam playbooks to know.
- ✦ reviewed
Peptide drugs & therapeutics: an overview (2026)
Peptide drugs are medicines made of short amino-acid chains. What they are, how they differ from pills, the main approved classes, and why most are injected.
- ✦ reviewed
Peptides for beginners: the complete getting-started guide (2026)
New to peptides? The fundamentals that prevent most beginner trouble: understand the compound, verify your source, reconstitute and dose accurately, inject safely, track honestly.
- Weight Loss✦ reviewed
Oral GLP-1s in 2026: Rybelsus, orforglipron, and what's next
Oral GLP-1s explained: peptide pills (Rybelsus) need empty-stomach dosing; small molecules (orforglipron) don't. Potency trade-offs and where the field is heading.
- Weight Loss✦ reviewed
Next-gen multi-agonists: dual, triple, and amylin combos (2026)
The shift from single to multi-agonist metabolic drugs: tirzepatide, retatrutide, survodutide, CagriSema. How each works, what's approved, and the safety caveat.
- Growth Hormone✦ reviewed
MK-677 (ibutamoren): does the oral GH secretagogue work? (2026)
MK-677 (ibutamoren) reliably raises IGF-1 and lean mass — but not strength, and it worsens insulin sensitivity. The evidence, side effects, and who should avoid it.
- Weight Loss✦ reviewed
Microdosing GLP-1s (Ozempic, tirzepatide): does it work? (2026)
Microdosing GLP-1s uses doses below the weight-loss range for gentler effects. What it is, why people do it, and the honest evidence — no microdose trials exist.
- Immune & Gut✦ reviewed
Is KPV safe, and should you cycle it? (2026)
KPV's anti-inflammatory mechanism looks safe, but there are no human trials. Do you need to cycle it or can you run it year-round? What the evidence actually supports.
- Longevity✦ reviewed
Khavinson peptide bioregulators: the short-peptide family explained (2026)
Khavinson short-peptide bioregulators (Epitalon, Vilon, Thymalin/Thymogen) explained: the gene-regulation theory, the real Russian-but-preclinical evidence, and dosing.
- ✦ reviewed
Is this peptide overpriced? Price-per-mg explained (2026)
Compute price-per-mg to judge any peptide price fairly. Worked examples, why vial size hides the real cost, and when a low per-mg figure is a red flag, not a bargain.
- Weight Loss✦ reviewed
Is Ozempic a peptide? GLP-1 mechanism of action explained (2026)
Yes — Ozempic (semaglutide) is a 31-amino-acid peptide analog of GLP-1. How it works (mechanism of action), why it's injected, and which GLP-1 drugs aren't peptides.
- Weight Loss✦ reviewed
GLP-1s & mental health: mood, anxiety & suicidal thoughts (2026)
Do Ozempic and Mounjaro affect mood or cause suicidal thoughts? The FDA and EMA found no causal link and removed the warning. What the evidence says on mood and anxiety.
- Weight Loss✦ reviewed
GLP-1s and heart rate / HRV: is the increase normal? (2026)
A modest resting heart-rate rise is a known GLP-1 class effect, usually alongside cardiovascular benefit. Why wearable HRV dips, and the red flags that need care.
- Weight Loss✦ reviewed
GLP-1 and cancer headlines: what the evidence actually says (2026)
Most GLP-1 cancer headlines are observational, not causal. What randomized evidence shows on overall risk, the thyroid signal, and how to read the news.
- Longevity✦ reviewed
FOXO4-DRI vs dasatinib + quercetin: senolytics compared (2026)
FOXO4-DRI vs dasatinib + quercetin senolytics: D+Q has early human pilots, FOXO4-DRI is mouse-only. How they compare on evidence, form, safety — and the anti-aging hype.
- Weight Loss✦ reviewed
Foundayo (orforglipron) is FDA approved: what it means (2026)
Foundayo (orforglipron) is the first take-anytime oral GLP-1 pill, FDA-approved April 2026. Efficacy (~12% weight loss), pricing, and how it compares to injectables.
- Cognitive✦ reviewed
Dihexa and cancer risk: the HGF/c-Met question (2026)
Dihexa activates HGF/c-Met — a major oncogenic pathway that cancer drugs block. Does it raise cancer risk? The mechanism, missing safety data, and who should avoid it.
- Weight Loss✦ reviewed
CagriSema deep dive: the GLP-1 + amylin combo explained (2026)
CagriSema pairs semaglutide with the amylin analog cagrilintide for ~20-22% weight loss in REDEFINE 1. Mechanism, the 'missed expectations' story, and how it compares.
- Weight Loss✦ reviewed
Cagrilintide: the amylin analog for weight loss explained (2026)
Cagrilintide is Novo's long-acting amylin analog — ~11% weight loss alone in Phase 2, and the amylin half of CagriSema. How amylin works and where it fits.
- Recovery✦ reviewed
ARA-290 (cibinetide): the nerve-repair peptide — what's proven? (2026)
ARA-290 (cibinetide) is an EPO-derived nerve-repair peptide with real human trials in sarcoid neuropathy. What's proven, what's hype, and the risks — evidence-led.
- ✦ reviewed
Alcohol and peptides: what interacts, beyond GLP-1s (2026)
The GLP-1–alcohol interaction is real: harder hits, GI, blood sugar, less craving. Research peptides have little data, but alcohol undermines recovery, sleep, and composition.
- Weight Loss✦ reviewed
Alcohol and GLP-1s: what to know before you drink (2026)
No absolute ban for most, but alcohol on a GLP-1 hits harder, worsens GI effects, adds calories, and can affect blood sugar. Moderation, awareness, and when to ask a clinician.
- Skin & Anti-Aging✦ reviewed
Wilson's disease and GHK-Cu: a hard contraindication explained (2026)
GHK-Cu is contraindicated for Wilson's disease. Carrier vs disease distinction, topical vs injectable risk, what to test, what to do if you've used it.
- Longevity✦ reviewed
Senolytic stack: Fisetin, Dasatinib + Quercetin, FOXO4-DRI (2026 guide)
Senolytic stack: Fisetin (Phase 2), Dasatinib + Quercetin (Phase 2), FOXO4-DRI. Mechanism, dosing, monitoring, and fit alongside rapamycin/metformin.
- Recovery✦ reviewed
Post-surgical recovery peptide stack: BPC-157 + TB-500 + GHK-Cu protocol
12-week protocol for post-orthopedic recovery. Mechanism breakdown, evidence tiers, dosing, regulatory status, when to consider and when not to.
- Sexual Health✦ reviewed
PT-141 nausea management: how to actually use bremelanotide without feeling sick
Why PT-141 causes nausea, how to dose-titrate to reduce it, when to switch to nasal route, what doesn't work. Clinical guide written for users and prescribers.
- Sexual Health✦ reviewed
Peptides for PSSD (Post-SSRI Sexual Dysfunction) recovery: 2026 protocols
Real condition, underserved by mainstream care. Why peptides target the neural-signaling layer SSRIs disrupted, evidence-tier reality, what protocols people are actually trying.
- Skin & Anti-Aging✦ reviewed
Post-laser peptide protocol: hour-by-hour skin recovery guide (2026)
Hour-by-hour skin recovery protocol for fractional laser, microneedling, and chemical peels. What to apply, what to avoid, when to resume normal routine.
- Cognitive✦ reviewed
Post-COVID brain fog peptide recovery: what works in 2026
Cerebrolysin, Semax, Selank + methylene blue protocols for long-COVID cognitive dysfunction. Evidence tiers, community protocols, regulatory context. Updated 2026.
- ✦ reviewed
Personal genomics services compared (2026): 23andMe, Nebula, Sequencing.com, Dante Labs, Dark Bio, and clinical PGx — what to actually use
What to use after 23andMe's bankruptcy. Honest comparison of Nebula, Dante, Sequencing.com, Dark Bio, and clinical PGx — by use case, cost, and data ownership.
- ✦ reviewed
Peptide storage, handling, and injection safety (2026)
Store cold and dark, refrigerate reconstituted vials, never shake or freeze-thaw. Sterile injection technique, and the side effects that mean stop and seek care.
- ✦ reviewed
Peptide injection technique for beginners (2026)
How to inject peptides safely: subcutaneous technique, sterile basics, step-by-step clean injection, site rotation, and telling a normal reaction from an infection warning sign.
- Weight Loss✦ reviewed
Peptide injection-site reactions: itching, lumps, redness & bruising (2026)
Itchy, red, lumpy, or bruised injection sites from peptides or GLP-1s? Usually benign. What's normal, how to prevent it with technique, and the real red flags.
- ✦ reviewed
Do you need a doctor to inject peptides? Self-injection, prep & starting safely (2026)
Do you need a doctor to inject peptides, or can you self-inject? How to prepare, start dosing low and slow, use sterile technique, and when you must involve a clinician.
- Weight Loss✦ reviewed
Injection anxiety: how to stop dreading the weekly shot (2026)
Needle anxiety makes people quit treatments that work. Why anticipation is worse than the shot, the technique fixes that help most, and when it's true phobia.
- Longevity✦ reviewed
NAD+ precursors (NMN, NR) in longevity protocols: honest 2026 review
NAD+ precursors evidence: biomarker Phase 2 data, no clinical longevity trials, NR vs NMN comparison, and where they fit in a longevity stack.
- ✦ reviewed
MTHFR variants and peptide therapy: separating real signal from supplement-industry noise (2026)
MTHFR affects folate and B12 — not BPC-157, GHK-Cu, semaglutide, or most peptides. When MTHFR matters clinically, why 'MTHFR-personalized protocols' are marketing.
- Skin & Anti-Aging✦ reviewed
Peptides for menopause skin thinning: a complete protocol guide
Why standard anti-aging products disappoint perimenopausal users, and what actually works. GHK-Cu + Matrixyl 3000 protocol, HRT compatibility, realistic timelines.
- Longevity✦ reviewed
Longevity biomarkers worth tracking in 2026: epigenetic clocks, ApoB, DunedinPACE, and what actually moves
Which biomarkers actually predict longevity outcomes: DunedinPACE vs Horvath clocks, ApoB vs LDL, fasting insulin vs HbA1c. What to test, how often, what's overrated.
- Immune & Gut✦ reviewed
LL-37 (human cathelicidin): antimicrobial peptide honest guide (2026)
LL-37 human cathelicidin: mechanism, biofilm disruption, vitamin D dependence, wound-healing evidence, why clinical translation has been slow.
- Immune & Gut✦ reviewed
KPV peptide: mechanism, IBD evidence, and routes — the deep-dive (2026)
KPV mechanism (PepT1 uptake, NF-κB inhibition, mast-cell stabilization), strongest evidence in IBD and MCAS, and oral vs SC vs topical dosing.
- Recovery✦ reviewed
KPV peptide for Mast Cell Activation Syndrome (MCAS): protocols and evidence
Mast cell stabilizing tripeptide as adjunct for refractory MCAS. Where it fits in the treatment ladder, dosing protocols, evidence tiers, what to know before starting.
- Longevity✦ reviewed
Healthspan vs lifespan: why the distinction matters for peptide protocols (2026)
Why healthspan is the right target for peptide protocols, which peptides actually support it, why animal lifespan data rarely translates, and what to track.
- Weight Loss✦ reviewed
Tapering off GLP-1s without rebound: maintenance protocols for 2026
Three taper patterns that work — slow dose reduction, indefinite maintenance, Tesamorelin bridge. STEP-4 data, behavioral predictors of regain, what to do if your compounded supply ends.
- Weight Loss✦ reviewed
GLP-1 muscle preservation: what actually works (Tesamorelin, training, protein)
Four interventions that preserve lean mass during GLP-1 weight loss. Why Tesamorelin works as adjunct and AOD-9604 doesn't. DEXA-scan protocol for measurement.
- Skin & Anti-Aging✦ reviewed
GHK-Cu vs Tretinoin: the 2026 skin density study
Different mechanisms (dermal density vs surface turnover), different best-fits. When GHK-Cu wins, when Tretinoin wins, when to stack both. Clinical detail.
- Skin & Anti-Aging✦ reviewed
Argireline: the topical 'Botox alternative' — what it actually does (2026)
What Argireline actually does at clinical concentration. Mechanism vs Botox, real effect size on expression lines, stacking with SNAP-8, what to look for in a serum.
- Weight Loss✦ reviewed
CagriSema PDUFA date and FDA approval status: where it actually stands
No PDUFA date has been published. Novo filed Dec 2025, decision guided to Q4 2026. What REDEFINE showed, and why grey-market CagriSema isn't the trialled drug.
- Longevity✦ reviewed
The mouse study everyone got wrong, and the FDA letters that made bac water a drug
Median lifespan 742 to 834 days in Nature. There was no male arm, so "only in females" is invented. Plus FDA warning letters making bacteriostatic water a drug.
- Recovery
Peptides for tendinopathy: acute vs chronic protocols (2026 evidence guide)
Acute tendonitis vs chronic tendinosis — different protocols, different timelines. Mechanism, dosing, what eccentric loading adds, when to escalate to PRP.
- Weight Loss✦ reviewed
Tesofensine for weight loss: what the trials show (2026)
Tesofensine is a triple monoamine reuptake inhibitor (not a peptide). ~10% weight loss in Phase 2, but heart-rate and blood-pressure concerns stalled it.
- Weight Loss✦ reviewed
Tesamorelin (Egrifta): FDA-approved visceral fat reduction + 2026 off-label use
Yes — tesamorelin (Egrifta) is FDA-approved, but only for HIV-associated lipodystrophy. What that covers, the off-label visceral-fat use, and the 2026 status.
- Cognitive✦ reviewed
Semax side effects: overstimulation & the mania question (2026)
Semax side effects explained: anxiety, irritability, insomnia and the wired feeling — plus an honest look at the rare mania/psychosis reports and who should avoid it.
- ✦ reviewed
Peptide reconstitution and dosing math, explained (2026)
Reconstitute with bacteriostatic water and calculate dose: units = (target ÷ total peptide) × units of water. Avoid the classic vial-total and insulin-unit errors.
- Weight Loss✦ reviewed
Rybelsus vs Orforglipron: oral GLP-1 head-to-head (2026 evidence guide)
Peptide vs small-molecule oral GLP-1. Bioavailability, fasting requirements, weight-loss data, FDA timeline, and which patients should choose which.
- Immune & Gut
Thymosin α-1 (Zadaxin): mechanism, Phase 3 evidence, US access (2026)
Mechanism (T-cell maturation, Th1 polarization), HBV/HCV Phase 3 data, sepsis-adjunct evidence, FDA status, US compounding access.
- Weight Loss✦ reviewed
AOD-9604: the fat-loss peptide that failed Phase 2 (2026 honest review)
Why AOD-9604's Phase 2b weight-loss trial failed, why it's still sold, when it's reasonable as a stack addition, and what to use instead for actual fat loss.
- Recovery✦ reviewed
BPC-157 arginate vs acetate: why salt form matters for oral dosing (2026)
BPC-157 arginate vs acetate for oral use: only the arginate salt has real oral bioavailability; acetate is gut-destroyed. Chemistry, dosing, and how to verify via COA.
- Recovery✦ reviewed
BPC-157 timeline expectations: what week 0, 4, 8, and 12 actually look like (2026)
Honest week-by-week BPC-157 timeline for tendinopathy + recovery. When to feel changes, when to expect plateaus, what to do if nothing happens by week 6, decision points by cycle phase.
- Cognitive✦ reviewed
Dihexa: the '10 million times more potent than BDNF' peptide — honest 2026 review
Why Dihexa's BDNF-mimetic claim is misleading, the c-Met cancer-pathway concern, zero human trials, and what actually-evidenced cognitive interventions to use instead.
- Sleep
DSIP (Delta Sleep-Inducing Peptide): honest review and 2026 evidence
Honest evidence review of DSIP: 9-aa sleep peptide from 1977, modest sleep-architecture effect, clean safety profile, where it fits vs GH peptides and benzos.
- Longevity
Epitalon: telomerase claim, Russian evidence, honest 2026 review
Epitalon honest review: 4-aa pineal peptide, telomerase activation mechanism, Russian clinical studies, and why Western RCT validation hasn't happened.
- Sleep
GH peptides for sleep architecture: sermorelin, CJC-1295, ipamorelin (2026)
How sermorelin / CJC-1295 / ipamorelin amplify the SWS-triggered overnight GH pulse, polysomnography evidence, and protocols for sleep-primary vs body-comp goals.
- Skin & Anti-Aging✦ reviewed
Why GHK-Cu burns when you inject it (and how to fix it)
GHK-Cu stings because it's a copper complex — not a bad batch. Why it burns, what's normal vs a histamine reaction, and the dilution fix that actually works.
- Recovery✦ reviewed
How long do peptides take to work? Timelines by peptide (2026)
Realistic peptide timelines by compound: how long GLP-1s, BPC-157, GHK-Cu, Semax and GH peptides take to work — and the fair window before calling one a failure.
- ✦ reviewed
How to start a peptide stack safely (2026)
The rule that prevents most stacking harm: add one peptide at a time. Verify each source, dose conservatively, wait weeks between additions, track everything.
- ✦ reviewed
Peptide evidence grades (2026): the S-to-F report card
27 peptides graded S to F by published human evidence. Only GLP-1s earn an S; most sit B–C; popular hype compounds land at D. A grade is not a recommendation.
- Immune & Gut
Peptides for IBD and ulcerative colitis: adjunct protocols (2026)
How peptides (KPV, BPC-157, LL-37, Thymosin α-1) fit alongside biologics and 5-ASA for IBD/UC. Adjunct protocols, not replacement therapy.
- Immune & Gut
Peptides for leaky gut: BPC-157 + KPV + glutamine protocol (2026)
What 'leaky gut' is (intestinal permeability), peptide mechanisms for tight-junction support, and when peptides are reasonable adjunct vs conventional GI workup.
- Sexual Health✦ reviewed
PT-141 (bremelanotide) complete guide: dosing, the 6-hour window, nausea management (2026)
Operational PT-141 protocol: starting dose, the 6-hour window, nausea management, cardiovascular screening, frequency limits, combining with PDE5 inhibitors.
- Sexual Health✦ reviewed
Sermorelin for libido: GH peptides + testosterone interplay (2026 evidence review)
Mechanism breakdown for sermorelin's indirect libido benefit. Sermorelin vs TRT, when it makes sense, dosing, what evidence actually supports, honest limits.
- Sexual Health✦ reviewed
TRT and sexual health: when peptides help and when they don't (2026)
Low libido on TRT despite good testosterone? Often central arousal or estradiol balance, not testosterone dose. When PT-141, HCG, or PDE5 inhibitors fit.
- Sexual Health✦ reviewed
Arousal vs erectile dysfunction: why Viagra and PT-141 solve different problems (2026)
Two different problems, two different fixes. Erectile dysfunction is vascular (PDE5 inhibitors); low arousal is central (PT-141). How to tell which is yours.
- Recovery
BPC-157 transdermal patches: do they actually deliver peptide? (2026 honest review)
Why most BPC-157 patches don't deliver meaningful peptide. The skin-barrier biology, the engineering required, and what to ask vendors before paying.
- Cognitive✦ reviewed
Cognitive peptides for ADHD and focus: what the evidence supports (2026)
Can Semax and cognitive peptides help ADHD or focus? As adjuncts maybe, as medication replacements no. How peptides compare to stimulants, and the honest approach.
- Recovery✦ reviewed
GHK-Cu for joints and fascia: beyond skin repair (2026 evidence guide)
Why GHK-Cu's mechanism extends to cartilage, tendon, and fascia. Animal evidence, dosing routes, where to stack with BPC-157, honest limits in joint applications.
- Weight Loss✦ reviewed
Stacking peptides with GLP-1s: what people add and why (2026)
People stack BPC-157 (GI), GH-axis peptides (muscle), or amylin (more loss) with GLP-1s. What has a rationale, what's proven, and why a clinician belongs in the loop.
- ✦ reviewed
How to read a peptide certificate of analysis (COA) (2026)
What a peptide COA shows — identity (mass spec), purity (HPLC ≥98%), batch, sterility — and how to spot a fake. Independent lab, batch-matched, dated, recent.
- ✦ reviewed
How to verify a peptide vendor before you buy (2026)
Judge vendors on evidence: routine, batch-matched, independent third-party COAs — not website polish or shipping reviews. How to check before you order.
- ✦ reviewed
Peptide stacking: what's safe, what works, and what's hype (2026)
Stacking peptides multiplies sourcing risk and side effects on thin evidence. Which combos have a rationale, which are hype, and how to add them one at a time.
- ✦ reviewed
Peptide stacking safety and interactions (2026)
Stacking raises three risks: multiplied sourcing uncertainty, additive side effects, broken attribution. Why peptide interaction data is absent and how to manage it.
- Weight Loss✦ reviewed
Peptides in the Baltics: three countries, three completely different import rules
Lithuania allows 10 packages a month from outside the EU. Estonia bans postal delivery of internet-ordered medicines entirely. Latvia caps growth hormone at 14 days.
- ✦ reviewed
Where to buy peptides in the EU: the legitimate routes (2026)
Where to actually buy peptides in the EU: prescription GLP-1s via clinics and pharmacies, OTC cosmetic topicals, and the gray-market reality for research peptides.
- Weight Loss✦ reviewed
GLP-1s and contraception: tirzepatide and semaglutide carry opposite warnings
Tirzepatide needs backup contraception for 4 weeks after every dose increase. Semaglutide has no contraceptive warning — but a 2-month pre-pregnancy washout.
- Growth Hormone✦ reviewed
Tesamorelin cannot give you abs, and the reason is anatomical
Tesamorelin cuts visceral fat behind the muscle. Abs are hidden by subcutaneous fat on top of it — and the label says it did nothing to that layer.
- Weight Loss✦ reviewed
Peptides in the Nordics: import rules, doping law and why possession can be a crime
Denmark opened third-country imports in January 2026. Norway bans prescription medicines by post from everywhere. And in three of five countries, possessing a GH peptide is a crime.
- Weight Loss✦ reviewed
New molecules, misread headlines and undocumented side effects: what the community found
Amycretin beat retatrutide, not the other way round. Apitegromab shifted tirzepatide's fat-to-lean ratio to 85:15. The 28 August FDA ruling never happened. Verified against primary sources.
- Weight Loss✦ reviewed
The cost squeeze is pushing people to split vials — and the guides they trust are paid
135 Reddit and 150 X posts, 17–23 Aug 2026. Cost drove everything: insurance drops, vial-splitting, grey-market moves — and a $499/month vendor tier on the site people use to vet sellers.
- ✦ reviewed
Peptides in perimenopause and menopause: what helps, what's hype (2026)
GLP-1s have real data for menopausal weight change; topical skin peptides are a low-risk adjunct; systemic collagen claims are weak. Peptides don't replace HRT.
- Recovery✦ reviewed
Peptides for sports injury recovery (2026): BPC-157, TB-500, GHK-Cu and what the evidence actually supports
Evidence-tier guide to recovery peptides. BPC-157 + TB-500 + GHK-Cu mechanisms, dosing, stacking, what the human evidence supports, when peptides plateau without PT.
- Weight Loss✦ reviewed
Ozempic face: why it happens and what to do about it (2026)
Ozempic face is facial volume loss from rapid weight loss — not the drug. Why cheeks hollow and skin sags, how to prevent it, and what actually fixes it (fillers, more).
- Longevity✦ reviewed
Peptide myths debunked: what's hype and what's real (2026)
The biggest peptide myths, debunked with evidence: 'natural means safe', 'no side effects', 'research chemical means tested', and 'peptides are all a scam'.
- Longevity✦ reviewed
Peptides for longevity (2026): what's backed by evidence, what's marketing
Which longevity peptides have real human evidence in 2026: GHK-Cu, GH-axis, BPC-157, senolytics, MOTS-c, Klotho. Honest evidence-tier breakdown of what works.
- Weight Loss✦ reviewed
Do GLP-1s Stop Working? Tolerance Breaks in 2026
Do GLP-1s build tolerance? Why they seem to stop working, whether a tolerance break or dose-splitting helps, and how plateaus and under-dosing differ. Not medical advice.
- Sexual Health✦ reviewed
Kisspeptin and emerging peptides for female sexual health (2026 evidence guide)
Why kisspeptin's upstream mechanism could fill the postmenopausal sexual health gap. Phase 2 data, comparison with PT-141 and flibanserin, realistic timeline.
- Weight Loss✦ reviewed
Loose skin after GLP-1 weight loss: why & what helps (2026)
Loose skin after Ozempic/Mounjaro is from rapid weight loss, not the drug. Why it happens, how much tightens naturally, what helps (training, peptides), and when surgery.
- Sexual Health✦ reviewed
Melanotan-II vs PT-141: safety-first comparison (2026 evidence review)
Documented fatal events, melanoma risk, priapism — why MT-II isn't a cheaper alternative to PT-141. Mechanism, FDA status, what to do.
- Skin & Anti-Aging
DIY copper peptide serum safety: pH, concentration, contamination (2026)
Why homemade GHK-Cu serums stain pillowcases, cause folliculitis, or stop working. Five common formulation errors and how to avoid them honestly.
- Longevity
FOXO4-DRI: the senolytic peptide that clears 'zombie cells' (2026 evidence review)
FOXO4-DRI clears senescent 'zombie' cells via FOXO4-p53 disruption. Baar 2017 animal data, zero human trials, community protocol + regulatory status.
- Weight Loss✦ reviewed
Does retatrutide really do the job of six peptides?
All six claims check out in trial data — but they're one 24% weight loss and five consequences, not six mechanisms. And retatrutide isn't approved anywhere.
- ✦ reviewed
Zero-peptide vials and "Faketide": the 2026 counterfeit wave explained
Vials sold as peptides contain no active ingredient — just hydroxyacetophenone. Plus the Paradigm Peptides conviction, and what it was actually for.
- Recovery✦ reviewed
Which peptides are gaining traction in 2026 — and why it's mostly one FDA vote
We analysed 1,992 community posts. BPC-157 up 150%, Epitalon 143%, GLP-1s down 30% — and 7 of the 10 risers are the same FDA 503A ballot compounds.
- Immune & Gut✦ reviewed
Peptide histamine reactions: it's usually not an allergy
MRGPRX2 makes mast cells release histamine with no sensitisation — hence first-dose reactions. And if every peptide causes swelling, check the bacteriostatic water.
- Weight Loss✦ reviewed
Lilly sues six retatrutide sellers: what the crackdown means
Six lawsuits, 200+ referrals to FDA and DOJ — over a drug with no submitted application. Then it showed up on Amazon. What the crackdown actually changes.
- Growth Hormone✦ reviewed
The three best-liked peptides in the community — and what's actually behind them
Tesamorelin, CJC-1295/Ipamorelin and MOTS-c tie at the top of community sentiment. One is FDA-approved with phase 3 data. One has never been properly trialled.
- Longevity✦ reviewed
Rapamycin, immune markers and the epigenetic clock: what the new data shows
A new rapamycin study moved immune markers but not the epigenetic clock. It's a conference abstract with ~12 per arm — and it tested daily, not weekly, dosing.
- Recovery✦ reviewed
BPC-157 healing timelines: animal vs human evidence reviewed
A 2025 systematic review screened 544 BPC-157 papers. 35 were animal studies. One involved humans. The healing timelines, and why they don't transfer to people.
- Cognitive✦ reviewed
Stacking Selank, progesterone and androsterone before a night out: the risk nobody names
Androsterone, progesterone and Selank all modulate GABA-A. Add alcohol and the effects are additive — the mechanism behind benzo-and-alcohol harm. What to know.
- Cognitive✦ reviewed
Methylene blue: the evidence, and the SSRI interaction nobody mentions
Methylene blue is a potent MAOI — with SSRIs it can cause serotonin syndrome. The mechanism is real, but human cognitive evidence is one 26-person study.
- Weight Loss✦ reviewed
Tirzepatide and the 45% mortality claim: why two studies disagree
BMJ says tirzepatide cuts deaths 45%. The randomised trial found noninferiority. Both are accurate — and the infection data shows why they disagree.
- Sleep✦ reviewed
Pinealon and Epitalon for sleep: what Huberman actually said
Huberman said Pinealon doubled his REM — then said he'd stopped taking it and that it has little human data. What the evidence for both peptides actually shows.
- Cognitive✦ reviewed
Low-dose daily tadalafil for the brain: what the evidence actually shows
Low-dose daily tadalafil is trending for dementia prevention. The trial missed significance, the biggest study found HR 0.99, and the signal belongs to sildenafil.
- Weight Loss✦ reviewed
VK2735 (Viking): the oral & injectable GLP-1/GIP drug explained (2026)
VK2735 is Viking's dual GLP-1/GIP drug in oral and injectable forms — up to ~14.7% (injectable) and ~12.2% (oral) weight loss in Phase 2. How it works and compares.
- ✦ reviewed
Peptides to avoid in pregnancy and breastfeeding (2026)
Almost no peptide has pregnancy or lactation safety data, so avoidance is the default. GLP-1s need a pre-conception washout; no-data research peptides mean don't.
- ✦ reviewed
Counterfeit peptides & fake Ozempic: how to spot them (2026)
Fake Ozempic has reached the US supply chain. How to spot counterfeit semaglutide pens and fake research peptides — lot/serial checks, COAs, and the red flags.
- Weight Loss✦ reviewed
Switching between GLP-1s: how to change drugs safely (2026)
Switching GLP-1s isn't a dose-for-dose swap — potencies differ. Start the new drug low and re-titrate, expect some early side effects, and let your prescriber set the conversion.
- Growth Hormone✦ reviewed
Hexarelin: the GHRP with desensitization caveats (2026)
Hexarelin is a potent growth-hormone-releasing peptide (GHRP) that desensitizes fast and raises cortisol and prolactin. Honest evidence, cardiac CD36 research, and risks.
- ✦ reviewed
Mixing peptides in one syringe: what's safe and what's not (2026)
Can you mix peptides in one syringe? Drawing compatible peptides for one shot is usually fine; storing a co-mixed blend isn't. Compatibility, pH, and the real risks.
- Longevity✦ reviewed
MOTS-c: the mitochondrial peptide, evidence & honest review (2026)
MOTS-c is a 16-amino-acid mitochondrial peptide that activates AMPK. Honest review: strong animal data, thin human evidence, unapproved research peptide — not proven.
- ✦ reviewed
Peptides without injecting: oral, nasal & topical options compared (2026)
What peptides you can take without needles — oral (Rybelsus, orforglipron), nasal (Semax, oxytocin), topical (GHK-Cu) — and how effective each route really is.
- Weight Loss✦ reviewed
Orforglipron: the first non-peptide oral GLP-1 explained
Eli Lilly's small-molecule oral GLP-1 — ATTAIN-1 results, why no fasting protocol needed, head-to-head vs Rybelsus and injectable GLP-1s, expected pricing, who should wait.
- Weight Loss✦ reviewed
Ozempic sulfur burps: why they happen & how to stop them (2026)
Ozempic sulfur (rotten-egg) burps come from slowed stomach emptying fermenting sulfur foods into hydrogen sulfide. Why they happen, how to stop them, and the red flags.
- ✦ reviewed
Peptide cost and pricing: how to judge what's fair (2026)
Why peptide prices vary so much, how to compare on price-per-mg, why gray-market retatrutide is cheap, and when a low price is a red flag for underdosing or counterfeits.
- ✦ reviewed
Peptides and recreational substances: what to know (2026)
How peptides interact with alcohol, stimulants, cannabis and MDMA: mostly unstudied, so caution. The one real signal — GLP-1s reducing cravings — plus the actual risks.
- Weight Loss✦ reviewed
What peptides are available in the EU: injectable and non-injectable (2026)
What peptides you can get in the EU: prescription GLP-1 injectables, oral Rybelsus, OTC cosmetic topicals — and why research peptides are harder to source here.
- Weight Loss✦ reviewed
GLP-1 cost-saving strategies, done safely (2026)
Safe GLP-1 savings (savings cards, insurance, pharmacy shopping) vs risky shortcuts (gray-market dose-splitting). How to cut cost without compromising safety.
- Weight Loss✦ reviewed
GLP-1s, gallbladder & pancreatitis: the risks explained (2026)
Do Ozempic and Mounjaro cause gallbladder or pancreas problems? GLP-1s modestly raise gallbladder-disease risk; pancreatitis is rare. Warning signs and what to do.
- Weight Loss✦ reviewed
GLP-1 fatigue and low energy: causes and fixes (2026)
Tired on a GLP-1? It's usually the calorie drop, dehydration, or low protein — not the drug. Eat enough, hydrate, protein, electrolytes. When fatigue needs a clinician.
- Weight Loss✦ reviewed
Ozempic & NAION: the eye risk warning explained (2026)
The EMA confirmed NAION as a very rare side effect of semaglutide (up to 1 in 10,000). What it means, why tirzepatide differs, and when vision changes are urgent.
- Weight Loss✦ reviewed
Retatrutide brain fog: why it happens & how to fix it (2026)
Retatrutide brain fog is usually secondary to under-eating, dehydration and low electrolytes — not the drug. Why it hits hardest on retatrutide, and how to fix it.
- Immune & Gut✦ reviewed
VIP nasal spray for CIRS and mold illness (2026)
VIP nasal spray is used in the CIRS / mold-illness Shoemaker protocol. Real immune biology and a small sarcoidosis trial, but weak CIRS-specific evidence.
- Weight Loss✦ reviewed
Adipotide (FTPP): fat-loss peptide risks explained (2026)
Adipotide (FTPP) kills fat-tissue blood vessels. Monkeys lost ~11% weight but had dose-limiting kidney toxicity. No human trials, not approved, genuinely high-risk.
- Longevity✦ reviewed
SS-31 (elamipretide): the mitochondrial peptide — what's proven? (2026)
SS-31 (elamipretide) is a cardiolipin-targeting mitochondrial peptide, FDA-approved in 2025 for Barth syndrome only. What's proven, what failed, and the anti-aging hype.
- Cognitive
Semax Nasal Spray Bioavailability: How the Nose-to-Brain Route Actually Works
How intranasal semax reaches the brain, bypassing the blood-brain barrier. Pharmacokinetics, evidence tiers, dosing, and what Western readers should know about the Russian evidence base.
- Weight Loss✦ reviewed
Pemvidutide (Altimmune): the GLP-1/glucagon drug for fat loss & liver (2026)
Pemvidutide is Altimmune's GLP-1/glucagon agonist — ~15.6% weight loss with standout lean-mass preservation and strong MASH data. How it works and compares.
- Immune & Gut✦ reviewed
Thymalin & Thymogen (Glu-Trp): the thymus bioregulators — review (2026)
Thymalin (thymus extract) and Thymogen (Glu-Trp dipeptide) explained: the immune-restoration evidence, why they're not thymosin alpha-1, dosing, and honest limits.
- Recovery
Oral BPC-157: Arginate Salt vs Acetylated — What Gastric Stability Actually Means
Which oral BPC-157 form survives the stomach better? Mechanisms, animal data, vendor quality issues, and which form fits gut-local vs systemic indications.
- Skin & Anti-Aging
GHK-Cu vs Retinol for Skin Barrier Repair: What the Evidence Actually Shows
Which is better for a damaged skin barrier: GHK-Cu copper peptide or retinol? Evidence, mechanism, side effects, and when to stack.
- Weight Loss✦ reviewed
GLP-1 titration schedules: going slow to avoid side effects (2026)
GLP-1 doses escalate gradually on purpose — hold each step ~4 weeks so the gut adapts. If side effects flare, hold don't push. Faster just means more nausea.
- Cognitive✦ reviewed
Nootropic peptide n=1: how to design a cognitive self-experiment with metrics that aren't BS (2026)
How to test whether a cognitive peptide actually works for you: baseline testing, objective metrics, on-off-on design, controlling placebo and confounders.
- Weight Loss✦ reviewed
GLP-1 pen problems: stuck pens, air bubbles & using it right (2026)
Why your Ozempic or Mounjaro pen won't turn (usually it's empty of a full dose), plus air bubbles, priming, missed doses, storage, and how to use a GLP-1 pen correctly.
- ✦ reviewed
Reconstituted peptide & BAC water shelf life: how long does it last? (2026)
How long a reconstituted peptide lasts: bacteriostatic vs sterile water, benzyl alcohol, refrigerated storage, what degrades it, and the discard signs to watch for.
- Weight Loss
MAHA + RFK Jr peptide access framework: what it means for compounded peptides
What the Make America Healthy Again policy framework does — and doesn't — change for compounded peptide access. Realistic timeline, what 'Ethical Suppliers' means, what patients should do.
- Weight Loss✦ reviewed
GLP-1 constipation: why it happens and how to fix it (2026)
GLP-1 constipation comes from slowed gut motility plus low food and fluid intake. Manage it proactively with fibre, fluids, and movement — and the red flags to watch.
- Weight Loss✦ reviewed
Living with a GLP-1: the daily-life guide (2026)
Day-to-day on a GLP-1: plateaus, fatigue, alcohol, constipation, and switching drugs — the common practical issues and their evidence-aligned answers.
- Weight Loss✦ reviewed
GLP-1 nausea: why it happens and how to manage it (2026)
GLP-1 nausea is dose-related, from slowed gastric emptying. Slow titration, smaller/slower meals, less fat, hydration. When persistent vomiting needs care.
- ✦ reviewed
Peptide storage and degradation: what actually matters (2026)
How peptides degrade — heat, light, freeze-thaw, oxidation, aggregation — and how to store them: cold, dark, sealed, unfrozen, small batches, and when to discard.
- ✦ reviewed
Traveling with peptides: cold chain, security & laws (2026)
How to travel with peptides: cold-chain planning, carry-on rules, declaring injectables and needles at security, documentation, and destination-law cautions.
- ✦ reviewed
Peptides and the menstrual cycle: does hormonal timing matter? (2026)
How the menstrual cycle changes peptide response across phases, why deliberate cycle-timing is unproven, and the one hard rule: reproductive intent and pregnancy safety.